Skip to main navigation Skip to search Skip to main content

Noncovalent Peptide Stapling Using Alpha-Methyl-l-Phenylalanine for α-Helical Peptidomimetics

  • Ross A.D. Bathgate
  • , Praveen Praveen
  • , Ashish Sethi
  • , Werner I. Furuya
  • , Rishi R. Dhingra
  • , Martina Kocan
  • , Qinghao Ou
  • , Adam L. Valkovic
  • , Isis Gil-Miravet
  • , Mónica Navarro-Sánchez
  • , Francisco E. Olucha-Bordonau
  • , Andrew L. Gundlach
  • , K. Johan Rosengren
  • , Paul R. Gooley
  • , Mathias Dutschmann
  • , Mohammed Akhter Hossain

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Peptides and peptidomimetics are attractive drug candidates because of their high target specificity and low-toxicity profiles. Developing peptidomimetics using hydrocarbon (HC)-stapling or other stapling strategies has gained momentum because of their high stability and resistance to proteases; however, they have limitations. Here, we take advantage of the α-methyl group and an aromatic phenyl ring in a unique unnatural amino acid, α-methyl-l-phenylalanine (αF), and propose a novel, noncovalent stapling strategy to stabilize peptides. We utilized this strategy to create an α-helical B-chain mimetic of a complex insulin-like peptide, human relaxin-3 (H3 relaxin). Our comprehensive data set (in vitro, ex vivo, and in vivo) confirmed that the new high-yielding B-chain mimetic, H3B10-27(13/17αF), is remarkably stable in serum and fully mimics the biological function of H3 relaxin. H3B10-27(13/17αF) is an excellent scaffold for further development as a drug lead and an important tool to decipher the physiological functions of the neuropeptide G protein-coupled receptor, RXFP3.

Original languageEnglish
Pages (from-to)20242-20247
Number of pages6
JournalJournal of the American Chemical Society
Volume145
Issue number37
DOIs
Publication statusPublished - 20 Sept 2023
Externally publishedYes

Cite this